The positive rates for anti-infliximab antibodies (human antichimeric antibodies; HACA), which is reported to influence the serum infliximab level25 were 27.3%, 23.1% and 12.5% in the 3, 6 and 10 ...
And, again, leadership is changing at the agency. Months after the HACA board of commissioners faced restructuring and decided to fire its CEO, City Council voted to eliminate the positions of the ...
Switching from established intravenous (IV) therapy to subcutaneous infliximab was associated with high treatment persistence, stable clinical disease activity, and consistent faecal calprotectin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results